Potential Budget Impact of Using a Cyanoacrylate Polymer Barrier Film Compared to Traditional Methods for the Management of Incontinence-Associated Dermatitis for Residents of a Skilled Nursing Facility

Speaker(s)

Campos D1, Loft B2, Stafford J3, Siabro V4, Palka-Santini M5
1Solventum Costa Rica, Pavas, Costa Rica, 2Solventum, London, ON, Canada, 3Solventum, Auckland, Auckland, New Zealand, 4Digital Health Outcomes, Kiev, Kiev, Ukraine, 5Solventum, Duesseldorf, NW, Germany

OBJECTIVES: To estimate the potential budget impact of utilizing a cyanoacrylate polymer barrier film (CPBF) for the prevention and management of incontinence-associated dermatitis (IAD) compared to traditional methods for aged residents of a skilled nursing facility in the United States

METHODS: A cost-minimization model was used to calculate the potential budget impact over 30 days of using CPBF versus traditional methods for the management of IAD with 100 aged residents of a skilled nursing facility. The parameters used in this calculation were taken from published literature, including the rates of incontinence for Category 1 IAD1 (7.6%)2 and Category 2 IAD (30%)2. The daily average number of incontinent episodes per patient was 6. The number of product applications per week were 42 for traditional method compared to 2 CPBF applications per week for redness (Category 1 IAD), and 3 applications per week for skin loss (Category 2 IAD). The cleansing and application time for traditional methods was 5 minutes and 2 minutes respectively, versus 2 minutes cleansing time and 45 seconds for application of CPBF. Local material and nursing costs were applied. All calculations were performed in US dollars

RESULTS: The total material costs for 100 patients over a one-month period were 48% ($6,725) lower when CPBF was used ($6,300) compared to the traditional method ($13,025). Total nursing time decreased by 71% fewer hours (2,060 hours) when CPBF was used (845 hours) compared to traditional methods (2,904 hours). The total savings associated with using the cyanoacrylate polymer barrier film was 66.9% ($41,480)

CONCLUSIONS: The use of a CPBF for the prevention and management of IAD is likely to reduce the burden of care for clinicians in a residential aged care setting and may yield significant cost and resource savings

Code

EE390

Topic

Economic Evaluation

Topic Subcategory

Budget Impact Analysis

Disease

No Additional Disease & Conditions/Specialized Treatment Areas